nicotine has been researched along with Respiratory Syncytial Virus Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatburn, RL; Gao, N; Raduka, A; Rezaee, F | 1 |
| Frischer, T; Kainz, K; Maedel, C; Reinweber, M; Zacharasiewicz, A | 1 |
| Auais, A; Mohtasham, L; Piedimonte, G; Scuri, M; Urrego, F | 1 |
| Nightingale, SL | 1 |
4 other study(ies) available for nicotine and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Electronic cigarette exposure disrupts airway epithelial barrier function and exacerbates viral infection.
Topics: Adolescent; Bronchi; Child; Electronic Nicotine Delivery Systems; Humans; Nicotine; Respiratory Aerosols and Droplets; Respiratory Syncytial Virus Infections; Respiratory Tract Infections | 2023 |
Increased severity of respiratory syncytial virus airway infection due to passive smoke exposure.
Topics: Austria; Female; Hospitalization; Humans; Infant; Infant, Newborn; Lung Diseases; Male; Nicotine; Oxygen; Parents; Prospective Studies; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Surveys and Questionnaires; Tobacco Smoke Pollution | 2018 |
Combined effects of chronic nicotine and acute virus exposure on neurotrophin expression in rat lung.
Topics: Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Female; Ganglionic Stimulants; Lung; Male; Nerve Growth Factor; Neurogenic Inflammation; Nicotine; Rats; Rats, Inbred F344; Receptor Protein-Tyrosine Kinases; Respiratory Syncytial Virus Infections; RNA, Messenger; Tobacco Smoke Pollution; Up-Regulation | 2009 |
From the Food and Drug Administration.
Topics: Animals; Campylobacter; Campylobacter Infections; Central Nervous System Stimulants; Chewing Gum; Drug Approval; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Humans; Immunoglobulins, Intravenous; Nicotine; Nonprescription Drugs; Polymethacrylic Acids; Polyvinyls; Population Surveillance; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Salmonella; Salmonella Infections; Salmonella Infections, Animal; Smoking Cessation; Tobacco Use Cessation Devices; United States; United States Food and Drug Administration | 1996 |